Back to resultsA Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares
Primary Purpose
Verrucae Vulgares
Status
Completed
Phase
Phase 2
Locations
Belgium
Study Type
Interventional
Intervention
Administration of zinkgluconaat or placebo
Sponsored by
About this trial
This is an interventional treatment trial for Verrucae Vulgares
Eligibility Criteria
Inclusion Criteria: Patients with verrucae vulgares Exclusion Criteria:
Sites / Locations
- University Hospital Ghent
Outcomes
Primary Outcome Measures
Disappearence of the verrucae vulgares after 3 months
Secondary Outcome Measures
Full Information
NCT ID
NCT00228332
First Posted
September 13, 2005
Last Updated
December 19, 2007
Sponsor
University Hospital, Ghent
1. Study Identification
Unique Protocol Identification Number
NCT00228332
Brief Title
A Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares
Official Title
A Double-Blind, Placebo-Controlled Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares
Study Type
Interventional
2. Study Status
Record Verification Date
December 2007
Overall Recruitment Status
Completed
Study Start Date
April 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
March 2006 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
University Hospital, Ghent
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
A Double-blind, placebo-controlled trial investigating the effect of a treatment with zinkgluconaat for verrucae vulgares
Detailed Description
A Double-blind, placebo-controlled trial investigating the effect of a treatment with zinkgluconaat for verrucae vulgares
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Verrucae Vulgares
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Single Group Assignment
Masking
Double
Allocation
Randomized
Enrollment
70 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Administration of zinkgluconaat or placebo
Primary Outcome Measure Information:
Title
Disappearence of the verrucae vulgares after 3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with verrucae vulgares
Exclusion Criteria:
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Annelies Stockman, MD
Organizational Affiliation
University Hospital, Ghent
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Ghent
City
Ghent
ZIP/Postal Code
9000
Country
Belgium
12. IPD Sharing Statement
Links:
URL
http://www.uzgent.be
Description
Website University Hospital Ghent
Learn more about this trial
A Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares
We'll reach out to this number within 24 hrs